JAMONY
TWST icon

Jacob Asset Management of New York’s Twist Bioscience TWST Stock Holding History

Jacob Asset Management of New York’s Portfolio TWST Stock Details TWST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,482
Closed -$228K – 69
2022
Q3 		$228K Sell
6,482
-317
-5% -$13.5K 0.25% 55
2022
Q2 		$238K Buy
6,799
+3,360
+98% +$119K 0.24% 61
2022
Q1 		$170K Buy
3,439
+170
+5% +$9.42K 0.1% 70
2021
Q4 		$253K Sell
3,269
-274
-8% -$28.1K 0.11% 72
2021
Q3 		$379K Buy
+3,543
New +$406K 0.14% 70

Other funds holding TWST

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
VOYA Investment Management
VOYA Investment Management Atlanta, Georgia $96.1B AUM 40.06% 1-Year Est. Return

Jacob Asset Management of New York's TWST Position: Q4 2022 in Review

Jacob Asset Management of New York sold out of Twist Bioscience (TWST) in Q4 2022, closing a stake of 6,482 shares — an estimated $228K sold.

Jacob Asset Management of New York first reported a position in TWST in Q3 2021 and held it in 5 quarters. The position peaked at $379K in Q3 2021. 199 funds tracked by Wall St. Rank hold TWST as of Q4 2022.

  • Jacob Asset Management of New York reported no remaining Twist Bioscience position as of Q4 2022 after selling out during the quarter.
  • Jacob Asset Management of New York sold 6,482 Twist Bioscience shares in Q4 2022, an estimated $228K.
  • Jacob Asset Management of New York first reported a position in Twist Bioscience in Q3 2021 and held it in 5 quarters.
  • Jacob Asset Management of New York's Twist Bioscience position peaked at $379K in Q3 2021.
  • 199 funds tracked by Wall St. Rank held Twist Bioscience as of Q4 2022.

Based on Jacob Asset Management of New York's 13F filing for Q4 2022, filed 14 Feb 2023.